申请人:PHENEX DISCOVERY VERWALTUNGS-GMBH
公开号:US20200352931A1
公开(公告)日:2020-11-12
The present invention relates to novel compounds which act as modulators of indoleamine 2,3-dioxygenase (IDO1) and to the use of said compounds in the prophylaxis and/or treatment of diseases or conditions mediated by indoleamine 2,3-dioxygenase. The invention further relates to pharmaceutical compositions comprising the novel compounds.